Immunosuppression in adult female B6C3F1 mice by chronic exposure to ethanol in a liquid diet

Protective Effects of Diallyl Sulfide against Thioacetamide-Induced Toxicity: A Possible Role of Cytochrome P450 2E1

Effects of diallyl sulfide (DAS) on thioacetamide-induced hepatotoxicity and immunotoxicity were investigated. When male Sprague-Dawley rats were treated orally with 100, 200 and 400 mg/kg of DAS in corn oil for three consecutive days, the activity of cytochrome P450 (CYP) 2E1-selective p-nitrophenol hydroxylase was dose-dependently suppressed. In addition, the activities of CYP 2B-selective benzyloxyresorufin O-debenzylase and pentoxyresorufin O-depentylase were significantly induced by the treatment with DAS. Western immunoblotting analyses also indicated the suppression of CYP 2E1 protein and/or the induction of CYP 2B protein by DAS. To investigate a possible role of metabolic activation by CYP enzymes in thioacetamide-induced hepatotoxicity, rats were pre-treated with 400 mg/kg of DAS for 3 days, followed by a single intraperitoneal treatment with 100 and 200 mg/kg of thioacetamide in saline for 24 hr. The activities of serum alanine aminotransferase and aspartate aminotransferase significantly elevated by thioacetamide were protected in DAS-pretreated animals. Likewise, the suppressed antibody response to sheep erythrocytes by thioacetamide was protected by DAS pretreatment in female BALB/c mice. Taken together, our present results indicated that thioacetamide might be activated to its toxic metabolite(s) by CYP 2E1, not by CYP 2B, in rats and mice.

Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression

The effect of 1,8-cineole on cytochrome P450 (CYP) expression was investigated in male Sprague Dawley rats and female BALB/c mice. When rats were treated orally with 200, 400 and 800 mg/kg of 1,8-cineole for 3 consecutive days, the liver microsomal activities of benzyloxyresorufin- and pentoxyresorufin-omicron-dealkylases and erythromycin N-demethylase were dose-dependently induced. The Western immunoblotting analyses clearly indicated the induction of CYP 2B1/2 and CYP 3A1/2 proteins by 1,8-cineole. At the doses employed, 1,8-cineole did not cause toxicity, including hepatotoxicity. Subsequently, 1,8-cineole was applied to study the role of metabolic activation in thioacetamide-induced hepatotoxicity and/or immunotoxicity in animal models. To investigate a possible role of metabolic activation by CYP enzymes in thioacetamide-induced hepatotoxicity, rats were pre-treated with 800 mg/kg of 1 ,8-cineole for 3 days, followed by a single intraperitoneal treatment with 50 and 100 mg/kg of thioacetamide in saline. 24 h later, thioacetamide-induced hepatotoxicity was significantly potentiated by the pretreatment with 1,8-cineole. When female BALB/c mice were pretreated with 800 mg/kg of 1,8-cineole for 3 days, followed by a single intraperitoneal treatment with 100 mg/kg of thioacetamide, the antibody response to sheep red blood cells was significantly potentiated. In addition, the liver microsomal activities of CYP 2B enzymes were significantly induced by 1,8-cineole as in rats. Taken together, our results indicated that 1,8-cineole might be a useful CYP modulator in investigating the possible role of metabolic activation in chemical-induced hepatotoxicity and immunotoxicity.

Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice

Whether immunological responses are involved in initiation and progression of alcoholic liver disease is unclear. We describe a mouse model of alcoholic liver injury characterized by steatosis and hepatic inflammation initiated by a recall immune response. Mice immune to Listeria monocytogenes fed a liquid diet containing ethanol and challenged with viable bacteria developed steatosis within 24 h and, at a later time, elevated serum alanine aminotransferase levels, indicating more liver damage in this group. Listeria antigen also induced steatosis and increased serum alanine aminotransferase levels in immune ethanol-consuming mice. The production of tumour necrosis factor by a recall immune response in this model is a major, but not the only, component in initiation of alcoholic liver disease.

Ethanol inhibition of phagocytosis and superoxide anion production by microglia

Ethanol consumption has been associated with aberrant immune responses resulting in increased susceptibility to infection including opportunistic infections of the central nervous system. We have investigated the effects of chronic ethanol treatment on phagocytosis and production of superoxide anion by microglia. Phagocytosis of radio-labeled opsonized E. coli was markedly suppressed by treating microglia with ethanol. The unstimulated synthesis of superoxide anion was not altered by ethanol treatment of microglia, but ethanol treatment effectively suppressed phorbol-12 myristate-13 acetate-stimulated microglia superoxide anion production. The results indicate that ethanol inhibition of microglia function may play a role in increased susceptibility for central nervous system infections, particularly in immunocompromised subjects.

Effect of ethanol on B cell expression of major histocompatibility class II proteins in immunized mice

Acute or chronic exposure to ethanol (EtOH), as well as other stimuli that induce a neuroendocrine stress response, can decrease the expression of MHC class II proteins (immune-associated antigens, Ia) on B cells and macrophages. In a mouse model for binge drinking, it has been shown that this decrease is caused by EtOH-induced increases in endogenous glucocorticoids. Decreased Ia expression would be expected to suppress T-dependent humoral responses, and such suppression has been noted in our model. However, it has been reported that activated B cells are much less susceptible to glucocorticoid-induced decreases in Ia expression than are resting B cells. Thus, it is not clear that the decreased Ia observed in our previous studies with non-immunized mice could account for decreased humoral responses, because it has not been directly determined that decreased Ia expression occurs in immunized mice. To examine this issue, splenocytes from mice immunized with sheep erythrocytes were studied by flow cytometry. Mice were treated with EtOH by gavage and immunized 12 h later, because our previous results indicate that this produces maximal suppression of the humoral response. In immunized mice, EtOH decreased Ia expression on B cells at 6 and 12 h after immunization, but not at 24 or 74 h. In a dose-response study, a substantial decrease in Ia expression on B cells was observed at an EtOH dosage of 6.0 or 7.0 g/kg. Thus, decreased Ia expression is a potential mechanism for EtOH-induced suppression of the humoral response. A glucocorticoid antagonist (RU 486) partially blocked the EtOH-induced decrease in Ia expression, suggesting that glucocorticoids are involved in the reduction of Ia expression in immunized mice. Direct administration of corticosterone to produce blood levels comparable to those noted in EtOH-treated mice did not significantly decrease Ia expression, but Ia expression tended to be lower in mice treated with corticosterone. Taken together, these results indicate that glucocorticoids play some role in decreasing Ia expression in immunized mice, but they are less important than in non-immunized mice.

Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs

BACKGROUND

We have previously reported that nonsteroidal anti-inflammatory drugs inhibit lung tumorigenesis induced by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mice.

PURPOSE

The aims of this study were to determine if NNK suppresses humoral (i.e., antibody) and cellular immune responses in mice and if nonsteroidal anti-inflammatory drugs could attenuate these immune responses.

METHODS

Female A/J mice (7-8 weeks old) were fed nonsteroidal anti-inflammatory drugs starting 2 weeks before the beginning of NNK treatment (9.1 mg per mouse in total) and continuing through the 7 weeks of NNK treatment. Eight groups (two control groups and six experimental groups) of 10 mice each were used per experiment. Animals in the two control groups received the same diet and water as animals in the six experimental groups; one control group received no nonsteroidal anti-inflammatory drugs or NNK and the other control group received only NNK. The primary humoral and cellular immune responses to the various treatments were assayed by the plaque-forming cell technique and by measurement of natural killer cell cytotoxic activity, respectively. At the end of each experiment, the animals were killed, blood was collected, plasma was prepared, and levels of the immune system modulator prostaglandin E2 were measured.

RESULTS

NNK treatment inhibited the plaque-forming cell response by approximately 50%; this inhibition was attenuated by treatment with sulindac or acetylsalicylic acid (P = .0001 for both). In contrast, treatment with naproxen, which had no chemopreventive (i.e., tumor inhibitory) efficacy, further increased by 26% (P = .05) the immunosuppressive effect of NNK. The cytotoxic activity of splenic natural killer cells against YAC-1 cells was reduced by 60% (P = .002); treatment with acetylsalicylic acid (254 mg/kg of diet) reduced the NNK-induced natural killer cell cytotoxicity inhibition by 50% (P = .02), whereas the administration of the specific cyclooxygenase-2 inhibitor NS-398 (7 mg/kg of diet) resulted in an almost complete recovery (approximately 95%, P = .04) of natural killer cell activity. The prostaglandin E2 plasma concentration was approximately 100% greater in NNK-treated mice than in untreated mice. Treatment of the mice with nonsteroidal anti-inflammatory drugs attenuated this elevation (from approximately 25% to 100%), and NS-398 (7 mg/kg of diet) was the most effective (100%).

CONCLUSIONS AND IMPLICATIONS

The ability of various nonsteroidal anti-inflammatory drugs to inhibit NNK-induced carcinogenesis appears to be directly related to the ability of these drugs to inhibit NNK-induced immunosuppression. Our results suggest that the chemopreventive effect of nonsteroidal anti-inflammatory drugs may be mediated through the modulation of prostaglandin E2 synthesis.

Ethanol ingestion inhibits cell-mediated immune responses of unprimed T-cell receptor transgenic mice

This paper introduces a transgenic (Tg) mouse in which the majority of the CD4-bearing T cells have T-cell receptors that react with ovalbumin (OVA) as a model for ethanol research. Although these Tg animals were bred onto the BALB/c genetic background, a strain generally considered to be nonpreferring in ethanol consumption, we determined that BALB/c mice would consume an ethanol-containing liquid diet, without significant mortality, and assessed alteration of specific immune responses. BALB/c, C57BL/6 (B6), or (BALB/c x C57BL/6)F-1 hybrid (CB6F1) mice were fed LED containing 35, 30, 25, or 20% ethanol-derived calories. Significant mortality (> 40%) was seen only in BALB/c and pronounced weight loss was seen in BALB/c, B6, CB6F1 mice when they were fed the diet containing the greatest ethanol concentration (LED35). Diets containing lesser amounts of ethanol did not cause mortality. Liquid diets containing > or = 30% ethanol-derived calories significantly impaired the chicken gamma-globulin-specific delayed hypersensitivity responses in BALB/c, B6, and CB6F1mice without significantly affecting the humoral immune response to sheep red blood cells. We show that immunization of the Tg mice is not required for the development of a vigorous "delayed hypersensitivity" response to OVA or the I-Ad-restricted peptide OVA323-339 in mice fed standard solid lab chow or liquid control diet. In marked contrast, OVA Tg mice fed ethanol show a profound inhibition of this immune response, indicating that ethanol-induced inhibition of cell-mediated immunity occurs independently of antigen priming.

Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes

We have recently reported that the effects of TCDD on the in vitro antibody response can vary considerably depending on the serum conditions used in the culture media. To further investigate this phenomenon, studies were performed to compare the effects of TCDD on both splenocyte antibody responses and P450 enzyme induction (EROD) in primary hepatocytes (HPTC) derived from B6C3F1 and DBA/2 mice when evaluated in the presence of either fetal bovine serum (FBS), newborn calf serum (NBCS) or normal mouse serum (NMS). The latter studies with NMS also included crossovers where splenocytes and HPTC from B6C3F1 mice were cultured in the presence of DBA/2 serum and vice versa. Results with NBCS showed comparable suppression of antibody responses by TCDD in splenocytes from B6C3F1 and DBA/2 mice where we detected IC50 values of 3.0 and 2.8 nM, respectively. In contrast, responses in the presence of NMS showed an Ah-dependency that was characterized by a dose-related suppression of antibody responses by B6C3F1 splenocytes, but a lack of suppression in the responses by DBA/2 splenocytes. Distribution studies with radiolabelled TCDD indicated that the observed profile of activity could not be attributed to a differential uptake of the chemical into splenocytes from B6C3F1 or DBA/2 under the various serum conditions. Serum was also found to modulate the TCDD-induced EROD activity in primary HPTC and the profile of activity was identical to the effects of TCDD on in vitro antibody responses. We observed an enhanced induction of EROD in the presence of NBCS (immunosuppressive conditions) and a lower induction in the presence of FBS (non-immunosuppressive conditions), each giving the same relative magnitude of induction regardless of the mouse strain used as the source of HPTC. In contrast, induction in the presence of NMS showed an Ah-dependency and resulted in a dose-related enhancement in EROD activity in B6C3F1 HPTC but decreased activity in the DBA/2 HPTC. Cross-over studies further showed that the pattern of effects on both splenocytes and HPTC was not altered by changing the strain of mouse used as the source of serum, where each gave equivalent results. These findings demonstrate that the Ah-dependency for the effects of TCDD on both the in vitro antibody response and P450 enzyme induction are modulated by the serum environment in which the cells are exposed. The studies with NMS indicate that it is the genotype of the lymphocyte (i.e., or the HPTC), and not the strain-specific hormone environment, which confers sensitivity to TCDD.(ABSTRACT TRUNCATED AT 400 WORDS)